Peripheral CHOP+ CD4+ T-cell subsets are quantitatively reduced and serologically linked to autoantibody production in pSS, highlighting CHOP expression as a potential blood biomarker and mechanistic target in pSS.
Abstract
Objective
Primary Sjögren's syndrome (pSS) is an autoimmune disease characterized by lymphocytic infiltration of exocrine glands and systemic immune dysregulation. Endoplasmic reticulum stress (ERS)-related transcription factor C/EBP homologous protein (CHOP) has been implicated in several autoimmune conditions, but its role in pSS remains unclear. This study aimed to delineate CHOP expression across peripheral CD4+ T-cell subsets in pSS and evaluate their clinical and diagnostic relevance, and investigate whether CHOP alterations were associated with the apoptotic response to ER stress.
Methods
Peripheral blood mononuclear cells from 28 newly diagnosed, treatment-naïve pSS patients and 25 age- and sex-matched healthy controls were analyzed by flow cytometry for CHOP expression in CD4+, CD8+, and regulatory T-cell (Treg) subsets. Standard laboratory tests measured complement, immunoglobulins, and autoantibodies. Additional experiments assessed apoptosis of CD4+ T cells after tunicamycin-induced ER stress. Group comparisons used Student's t-test or Mann-Whitney U test, correlations used Spearman's coefficient, and receiver operating characteristic (ROC) curves assessed diagnostic performance.
Results
CHOP was expressed at higher levels in CD4+ than CD8+ T cells in healthy individuals, with effector and central memory CD4+ subsets showing the greatest expression. pSS patients exhibited significantly reduced proportions of CHOP+ CD4+ T cells-including non-Treg and memory subsets-compared with controls. Within Tregs, CHOP expression was enriched in effector Tregs in health but selectively diminished in pSS. CHOP+ Treg subsets showed differential correlations with serum IgG, IgA, anti-Sm antibodies, and complement C4. ROC analysis yielded AUCs >0.90 for several CHOP+ CD4+ subsets distinguishing pSS from controls.
Conclusion
Peripheral CHOP+ CD4+ T-cell subsets are quantitatively reduced and serologically linked to autoantibody production in pSS. Their high diagnostic accuracy highlights CHOP expression as a potential blood biomarker and mechanistic target in pSS.
CD38+HLA-DR+CD8+ T cells are identified as a potential mechanistic link between Still's disease and MAS and highlight this subset as a candidate therapeutic target.
Greta Rogani, R. Erkens, A. Bodelón et al.· Arthritis & Rheumatology· 0 citations
Abatacept selectively modulates CD319/SLAMF7-expressing cytotoxic T cells and suppresses associated pro-fibrotic and pro-inflammatory cytokines, particularly in the fibroproliferative subtype, where CD319+ T cell reductions correlate with clinical improvement.
Mikel Gurrea-Rubio, Laura A. Cooney, Kohei Maeda et al.· Arthritis & Rheumatology· 0 citations
Objectives Autoimmune diseases such as primary Sjögren’s disease (pSjD) and systemic lupus erythematosus (SLE) share clinical and serological features, including type I interferon signatures, autoantibody formation, and chronic inflammation, but the underlying immunopathology is not the same. To support the development...
F. Szelinski, Ana-Luisa Stefanski, A. Wiedemann et al.· Frontiers in Immunology· 0 citations
Sjögren’s disease (SjD) is a chronic autoimmune condition marked by lymphocytic infiltration of exocrine glands and production of autoantibodies such as anti-SSA/Ro, anti-SSB/La, and rheumatoid factor. B lymphocytes play a central role in disease pathogenesis, driving autoantibody production and glandular damage, and c...
C. Iperi, Akhiya Anilkumar Rekha, Gustav Arvidsson et al.· bioRxiv· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.